Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 20/20 | 0.80 |
| ▸ | ESR1 | P03372 | 1/20 | 0.80 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.80 |
| ▸ | PGR | P06401 | 1/20 | 0.80 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.80 |
| ▸ | AR | P10275 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19260855 | 0.94 | NR1H4 (0.80) | NR1H4ESR1NR3C1PGRNR3C2 | |
| Turofexorate Isopropyl SCHEMBL274657 | 0.89 | NR1H4 (1.00) | NR1H4ESR1NR3C1PGRNR3C2 | |
| Turofexorate Isopropyl SCHEMBL29823687 | 0.89 | NR1H4 (1.00) | NR1H4ESR1NR3C1PGRNR3C2 | |
| Turofexorate Isopropyl SCHEMBL29382704 | 0.89 | NR1H4 (1.00) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL17883440 | 0.89 | NR1H4 (0.80) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL17873357 | 0.87 | NR1H4 (0.78) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL3738534 | 0.87 | NR1H4 (0.83) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL3734487 | 0.86 | NR1H4 (1.00) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL4523649 | 0.85 | NR1H4 (0.86) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL17873365 | 0.85 | NR1H4 (0.74) | NR1H4ESR1NR3C1PGRNR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017143134-A1 | FXR MODULATORS AND METHODS OF THEIR USE | ALIOS BIOPHARMA, INC. (US) | 2017-08-24 | — | — | WO | claimed |
| WO-2017143134-A1 | FXR MODULATORS AND METHODS OF THEIR USE | ALIOS BIOPHARMA, INC. (US) | 2017-08-24 | — | — | WO | disclosed |